Q4 2023 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2024-03-07 · accession 0001802806-24-000019
$339.4M
Reported value
6
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $132.2M | 38.9% | 11,831,461 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $81.5M | 24.0% | 6,131,079 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $80.1M | 23.6% | 8,677,951 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $41.0M | 12.1% | 4,866,499 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $2.4M | 0.72% | 3,878,148 | Common | SHARED |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $2.1M | 0.63% | 2,390,050 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.